康恩貝(600572)5月11日(ri)晚公(gong)(gong)(gong)告,公(gong)(gong)(gong)司(si)(si)(si)擬收購(gou)江(jiang)藥集(ji)團持有的(de)(de)(de)(de)江(jiang)西(xi)(xi)(xi)天(tian)施康公(gong)(gong)(gong)司(si)(si)(si)41%的(de)(de)(de)(de)股(gu)(gu)份。根據已簽訂(ding)的(de)(de)(de)(de)意(yi)向書,公(gong)(gong)(gong)司(si)(si)(si)將參與江(jiang)西(xi)(xi)(xi)天(tian)施康公(gong)(gong)(gong)司(si)(si)(si)41%股(gu)(gu)份的(de)(de)(de)(de)公(gong)(gong)(gong)開掛牌(pai)競(jing)(jing)買(mai)(mai)。若競(jing)(jing)買(mai)(mai)成功,公(gong)(gong)(gong)司(si)(si)(si)將獲得江(jiang)西(xi)(xi)(xi)天(tian)施康公(gong)(gong)(gong)司(si)(si)(si)100%股(gu)(gu)份。
江(jiang)西天(tian)施康公(gong)(gong)司(si)由總部、貴溪(xi)及余江(jiang)分公(gong)(gong)司(si)組成,下屬有江(jiang)西珍視(shi)明(ming)藥業有限公(gong)(gong)司(si)等5家(jia)子公(gong)(gong)司(si),主要產品有腸炎(yan)寧系列(lie)產品、夏(xia)天(tian)無系列(lie)產品、珍視(shi)明(ming)滴(di)眼液、牛黃上(shang)清膠囊等。2016年(nian)凈利5340萬元。